Surgical Pathology 2022 covers common surgical pathology. Pathology includes GI, hepatobiliary, breast, head & neck, endocrine, genitourinary, and soft tissue. Surgical Pathology 2022 discusses diagnosis basics and offers advice on overcoming diagnostic hurdles to help pathologists make correct diagnoses. A thorough immunohistochemical and molecular review aids diagnosis.
Goal audience:
Pathologists learn from CME.
Goals for Surgical Pathology 2022:
After CME instruction You can:
- Diagnostic features of well-differentiated lipomatous tumors.
- Discuss malignant cell characteristics for gastrointestinal mesenchymal tumor diagnosis.
- Here are the most common highly cellular spindle cell tumor diagnosis.
- Discuss WHO diagnostic criteria for lobular carcinoma in situ and e-cadherin immunohistochemistry for breast in-situ tumors’ pros and disadvantages.
- Learn about thyroid neoplasia’s molecular advances and tumor characterization problems.
- Differentiate chronic idiopathic inflammatory bowel illness from others for practical purposes.
- Custom immunohistochemical marker panels detect breast papillary lesions.
- Pathologic considerations affect prostate cancer grading patterns and reporting.
- Explore common and unusual eosinophilic kidney tumors. Discover these cancers’ morphologic and immunohistochemical markers.
- Use molecular testing to diagnose salivary gland lesions and understand cytopathologic and histopathologic features.
- How should HPV-related squamous cell carcinoma histologic and cytologic samples be evaluated?
- Histologic patterns and clinical-laboratory correlations help detect common liver diseases.
- Use common criteria to diagnose appendix inflammatory neoplastic illness.
- Body-wide neuroendocrine neoplasia symptoms.
- Learn about steroid-synthesizing tissue structure and function.
- Analyzing mastectomy and lumpectomy samples after neoadjuvant chemotherapy is difficult.
- Discuss the histology and clinical impact of breast myoepithelial and epithelial-myoepithelial lesions.
Program of Surgical Pathology 2022:
- An Approach to Well-Differentiated Lipomatous Tumors
John R. Goldblum, M.D. - Papillary Lesions of the Breast
Carmen Gomez-Fernandez, M.D. - Biopsy Evaluation of Non-Neoplastic Diseases of the Large Bowel: An Algorithmic Approach
Laura W. Lamps, M.D. - Thyroid Neoplasia: Inching Towards a Molecular Classification
Sylvia L. Asa, M.D., Ph.D. - Spindle Cell Tumors with a Focus on the Use of Ancillary Diagnostic Techniques
John R. Goldblum, M.D. - Lobular Carcinoma In-Situ and Problematic In-Situ Breast Lesions
Stuart J. Schnitt, M.D. - Salivary Gland Pathology: The Complementary Roles of Cytopathology and Histopathology and the Emergency of Molecular Diagnostics
Carmen Gomez-Fernandez, M.D. - Medical Liver Disease: A Basics Refresher Course
Laura W. Lamps, M.D. - Prostate Cancer 2022
Cristina Magi-Galluzzi, M.D., Ph.D. - Neuroendocrine Tumors: Hormones from Head to Tail
Sylvia L. Asa, M.D., Ph.D. - The Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens
Stuart J. Schnitt, M.D. - Beyond Acute Appendicitis: Fascinating Lesions of the Vermiform Appendix
Laura W. Lamps, M.D. - GIST and Beyond: An Approach to GI Mesenchymal Tumors
John R. Goldblum, M.D. - Practical Considerations of Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma
Carmen Gomez-Fernandez, M.D. - Myoepithelial and Combined Epithelial-Myoepithelial Lesions of the Breast
Stuart J. Schnitt, M.D. - Pink Renal Tumors: How Far Can You Go With Morphology
Cristina Magi-Galluzzi, M.D., Ph.D. - Steroidogenic Tumors: Germline Predisposition in Endocrine Neoplasia
Sylvia L. Asa, M.D., Ph.D. - Recent Advances in Bladder Cancer Classification, Grading, Staging and Reporting
Cristina Magi-Galluzzi, M.D., Ph.D.
Reviews
There are no reviews yet.